How to Use The Clinic's Injectable Pen (Step-by-Step)
How to Use The Clinic's Injectable Pen (Step-by-Step)The Clinic's...
Ipamorelin is a highly selective Growth Hormone Secretagogue (GHS) that targets the ghrelin receptor (GHS-R1a) to promote controlled, pulse-like growth hormone (GH) release in research models. Because of its precision and minimal off-target impact, Ipamorelin is widely used to explore metabolic regulation, recovery dynamics, and sleep-linked endocrine rhythms in a laboratory setting.
Within controlled environments, Ipamorelin is valued for its clean profile: low effect on cortisol and prolactin, stable GH-axis activation, and strong compatibility with synergistic peptides such as CJC-1295 and Sermorelin.
Ipamorelin exerts its primary effect by binding selectively to the ghrelin receptor (GHS-R1a). This receptor engagement initiates a signalling cascade that triggers pulsatile GH release from the anterior pituitary, mimicking physiologic secretion patterns without notable stimulation of ACTH or prolactin.
The Clinic standardises all cartridges to simplify research use and improve dose reproducibility.
| Clicks | Dose (mcg) |
|---|---|
| 6 clicks | 100 mcg |
| 9 clicks | 150 mcg |
Pen lasts for: 11 to 17 days
| Clicks | Dose (mcg) |
|---|---|
| 15 clicks | 250 mcg |
| 18 clicks | 300 mcg |
Pen lasts for: 6 to 7 days
Ipamorelin has been associated with:
All outcomes remain dependent on model, protocol, and research conditions, and should not be interpreted as therapeutic claims.